Table 2.

Patient demographics

Age (y)
    Median56
    Range41–81
Gender (n)
    Male11
    Female10
Karnofsky performance index (n)
    90–100%12
    80–90%6
    70–80%3
Tumor type (n)
    Breast7
    Colon6
    Esophagus4
    Stomach2
    Pancreas1
    Thyroid1
No. metastatic sites (n)
    15
    25
    ≥311
No. prior chemotherapy regimens (n)*
    05
    14*
    ≥212
  • *Four patients had received prior paclitaxel.